Montelukast does not appear to increase the risk for neuropsychiatric adverse events in children and adolescents, according to a study published in JAMA Pediatrics. Montelukast is a leukotriene ...

Teva Pharmaceutical Industries Limited’s TEVA share price has dipped by 13.89%, which has investors questioning if this is ...

Kinaset Therapeutics, a clinical-stage biopharmaceutical company developing inhaled therapeutics to treat serious respiratory diseases, today announced that the United States Food and Drug ...

Authenticated data presented in the Respiratory Drugs market report is based on findings of extensive primary and secondary research ...

No significant risks were seen for specific neuropsychiatric events individually or in any subgroup or sensitivity analysis, ...

New research into the use of beta agonists released this week raises concerns about the animal health and welfare of feedlot cattle. The peer-reviewed article, while acknowledging “significant ...

The global short-acting beta-agonists market, crucial medications for treating asthma and COPD, is poised for substantial growth according to recent market analysis. Starting at USD 675 million in ...

Green: These inhalers tend to be for long-acting beta-agonist preventer medication, most often used to help reduce symptoms of respiratory conditions like asthma or COPD. These must also be taken ...

As Lyndra Therapeutics works to advance long-acting oral drugs for a range of diseases, the Massachusetts-based biotech is tapping contracting juggernaut Thermo Fisher Scientific to help meet its ...

In patients with chronic obstructive pulmonary disease (COPD), the first year of using single-inhaler triple therapy is associated with slightly more major adverse cardiovascular events (MACE) than ...

7 said it would stop accepting beef fed Zilmax beginning next month. Below is an edited transcript of Grandin’s answers to Reuters’ questions. Zilmax and other beta-agonists, a class of non-hormone ...

The standard treatment for non-muscle invasive bladder cancer (NMIBC) is Bacillus Calmette-Guérin (BCG). However, despite it being effective, many patients experience recurrences, and others become ...